Fig. 4 | Signal Transduction and Targeted Therapy

Fig. 4

From: Multi-omics analysis reveals RNA splicing alterations and their biological and clinical implications in lung adenocarcinoma

Fig. 4

Regulatory pattern of DNA mutation and methylation on AASE in LUAD. a Box plot showing the ES event of TP53 were regulated by the splice site mutation of TP53. b Overview of the trans-sQTLs. The x-axis indicates the mutation positions and the y-axis indicates the splice sites across chromosomes. Bars vertical to the x-axis summarize the number of trans-sQTLs in each chromosome and bars parallel to the x-axis summarize the regulated ASEs within each chromosome. c Schematic plot showing the boundary regions of alternative exons. d Volcano plot showing the differential methylated CpG sites within the boundary regions of alternative exons in LUAD. e Summary of the 21 differentially methylated CpG sites that regulated their corresponding AS events. The X-axis represents the position of CpG sites across chromosomes and the Y-axis indicates the significance of correlation coefficients between CpG sites and corresponding ASEs. Red and blue dots stand for highly and lowly methylated CpG sites in LUAD, respectively. Ellipse indicates a positive (orange) or negative (blue) relationship between methylated levels of the CpG sites and the inclusion rate of corresponded alternative exons. f The number of seven types of AASEs regulated by methylated CpG sites across 30 cancer types. g The number of AP events positively (red) and negatively (blue) regulated by methylated CpG sites across 30 cancer types. h Bar plot showing the number of methylated CpG sites that regulated AP events in promoter regions, gene body regions, and intergenic regions (IGR) across 30 cancer types

Back to article page